Clinical Outcomes of Second-Line Chemotherapy after Progression on Nab-Paclitaxel Plus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma - Lee, Kyoungmin; Bang, Kyunghye; Yoo, Changhoon; Hwang, Inhwan; Jeong, Jae Ho; Chang, Heung-Moon; Oh, Dongwook; Song, Tae Jun; Park, Do Hyun; Lee, Sang Soo; Lee, Sung Koo; Kim, Myung-Hwan; et al. (Cancer research and treatment, 2020)
Keywords: Adenocarcinoma - diagnosis; Adenocarcinoma - drug therapy; Adenocarcinoma - etiology; Adenocarcinoma - mortality; Adult; Aged; Albumins - administration & dosage; Antineoplastic Combined Chemotherapy Protocols - adverse effects; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Deoxycytidine - administration & dosage; Deoxycytidine - analogs & derivatives; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Original; Paclitaxel - administration & dosage; Pancreatic Neoplasms - diagnosis; Pancreatic Neoplasms - drug therapy; Pancreatic Neoplasms - etiology; Pancreatic Neoplasms - mortality; Prognosis; Retreatment; Retrospective Studies; 의학일반; Second-line; Oxaliplatin; Gemcitabine; Nab-paclitaxel; Pancreatic neoplasms